Skip to content

AESCULAP BD660RRecalls & reported problems

Aesculap AG · GILLIES Tissue Forceps, straight, 6 1/8", (155 mm), delicate, toothed (1x2), non-sterile, reusable · Class 1

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04038653024117), received between Mar 16, 2021 and Mar 16, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Product Quality Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Product Quality Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 16, 2021Product Quality Problem; Product Quality Problem

    IT WAS REPORTED THAT THERE WAS AN ISSUE WITH BD660R - GILLIES TISSUE FORCEPS DEL 1X2 155MM. ACCORDING TO THE COMPLAINT DESCRIPTION, BURRS AND FRAGMENTS ON SERRATIONS ARE DETECTED DURING INCOMING GOODS INSPECTION. THERE WAS NO DESCRIBED PATIENT HARM BECAUSE NO PATIENT WAS INVOLVED. ADDITIONAL INFORMATION WAS NOT PROVIDED. THE MALFUNCTION IS FILED UNDER AAG REFERENCE (B)(4).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11497147 ↗

Other FORCEPS devices

All FORCEPS devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.